Грапипрант
- английское имяGrapiprant
- CAS №415903-37-6
- CBNumberCB03054518
- ФормулаC26H29N5O3S
- мольный вес491.61
- номер MDLMFCD16628076
- файл Mol415903-37-6.mol
химическое свойство
Температура плавления | >151°C (dec.) |
плотность | 1.29±0.1 g/cm3(Predicted) |
температура хранения | Sealed in dry,Store in freezer, under -20°C |
растворимость | Soluble in DMSO (up to at least 10 mg/ml) |
пка | 5.19±0.10(Predicted) |
форма | solid |
цвет | Off-white |
Стабильность | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
ИнЧИКей | HZVLFTCYCLXTGV-UHFFFAOYSA-N |
SMILES | C1(S(NC(NCCC2=CC=C(N3C4C=C(C)N=C(C)C=4N=C3CC)C=C2)=O)(=O)=O)=CC=C(C)C=C1 |
FDA UNII | J9F5ZPH7NB |
Словарь наркотиков NCI | grapiprant |
Грапипрант химические свойства, назначение, производство
Описание
Prostaglandin E2 (PGE2) activates four E prostanoid (EP) receptors, EP1-4. EP4 is a Gs protein-coupled receptor that, by elevating the second messenger cAMP, plays important roles in bone formation and resorption, cancer, and atherosclerosis. CJ-023423 is a potent and selective antagonist of the EP4 receptor (Ki = 13 and 20 nM for human and rat EP4, respectively). It inhibits PGE2-evoked elevation in intracellular cAMP in cells and, in vivo, reduces thermal hyperalgesia induced by intraplantar injection of PGE2. CJ-023423 reduces acute and chronic inflammatory pain in different mouse models.Использование
CJ-023423 is a potent and selective antagonist of E prostanoid 4 (EP4) receptor.Биологические функции
Grapiprant (CJ-023423) is an orally available, a potent and selective EP4 receptor antagonist that exhibits significant inhibitory effects on paw swelling, inflammatory biomarkers, synovial inflammation and bone destruction in AIA rats. Grapiprant is highly selective for the human EP4 receptor over other human prostanoid receptor subtypes. It also inhibits PGE2-evoked elevation in intracellular cAMP at the human and rat EP4 receptors with pA2 of 8.3 and 8.2 nM, respectively. In vivo, oral administration of grapiprant significantly reduces thermal hyperalgesia induced by intraplantar injection of PGE2 (ED50 = 12.8 mg/kg). It is also effective in models of acute and chronic inflammatory pain. Grapiprant significantly reduces mechanical hyperalgesia in the carrageenan model. Furthermore, it significantly reverses complete Freund′s adjuvant-induced chronic inflammatory pain response. It produces antihyperalgesic effects in animal models of inflammatory pain. Grapiprant is approved and widely used for treatment of osteoarthritis related pain in dogs. Grapiprant is classify as a non-cyclooxygenase inhibiting non-steroidal anti-inflammatory drug (NSAID).Побочные эффекты
Possible side effects of Grapiprant include: vomiting, drowsiness, diarrhoea, loss of appetite, blood or mucus in the stool, and reduced blood protein levels. The degree of reaction can vary from mild to severe, but if your dog experiences a loss of appetite or abnormal faeces, you should contact your veterinarian promptly.Грапипрант поставщик
поставщик | телефон | страна | номенклатура продукции | благоприятные условия | |
---|---|---|---|---|---|
+8613340353813 | China | 26 | 58 | ||
+86-0571-28186870; +undefined8613073685410 |
China | 990 | 58 | ||
+undefined-21-51877795 | China | 32836 | 60 | ||
+1-631-485-4226 | United States | 19553 | 58 | ||
00852-68527855 | China Hong Kong | 902 | 58 | ||
+8615255079626 | China | 23555 | 58 | ||
+8613073028829 | China | 2996 | 58 | ||
+1-708-310-1919 +1-13798911105 |
United States | 6393 | 58 | ||
+86-25-58227606 +86-15305155328 |
China | 4128 | 58 | ||
+86-852-30606658 | China | 24738 | 58 |